Cargando…

Multifocal tuberculosis on certolizumab pegol in a patient followed for rheumatoid arthritis

Tuberculosis must be considered in front of deterioration in general condition in patient with rheumatic disease under biological therapy. Rheumatologists may pay attention and screen infections before and after prescribing biological therapy.

Detalles Bibliográficos
Autores principales:	Hannech, Emna, Boussaid, Soumaya, Rekik, Sonia, Jemmali, Samia, Ajlani, Houda, Cheour, Elhem, Sahli, Hela, Elleuch, Mohamed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190679/ https://www.ncbi.nlm.nih.gov/pubmed/34136240 http://dx.doi.org/10.1002/ccr3.4307

Ejemplares similares

29 Juvenile idiopathic arthritis and osteogenesis imperfecta: an exceptional association
por: Emna, Hannech, et al.
Publicado: (2022)

Comorbidités et biothérapies au cours de la pandémie Covid-19 : quel impact chez les patients atteints de polyarthrite rhumatoïde ?
por: Hannech, E., et al.
Publicado: (2022)

Acute transverse myelitis revealing ankylosing spondylitis: A case report and literature review
por: Boussaid, Soumaya, et al.
Publicado: (2021)

16 Spectrum of infections during juvenile idiopathic arthritis
por: Dissem, Nouha, et al.
Publicado: (2022)

15 Fertility in juvenile idiopathic arthritis
por: Ammou, Ahlem Ben, et al.
Publicado: (2022)

14 Juvenile idiopathic arthritis: osteoporosis and fractures
por: Ammou, Ahlem Ben, et al.
Publicado: (2022)

13 Juvenile idiopathic arthritis and cardiovascular risk factors
por: Tbini, Houssem, et al.
Publicado: (2022)

12 Hip involvement in juvenile idiopathic arthritis: frequency and associated factors
por: Tbini, Houssem, et al.
Publicado: (2022)

11 Evaluation of doctors’ knowledge (excluding rheumatologists and pediatricians) of juvenile idiopathic arthritis
por: Tbini, Houssem, et al.
Publicado: (2022)

Association of SARS-COV2 and Lumbar Spine Fractures: Causal or Coincidental?
por: Boussaid, Soumaya, et al.
Publicado: (2022)

The synovial fluid fibroblast-like synoviocyte: A long-neglected piece in the puzzle of rheumatoid arthritis pathogenesis
por: Mahmoud, Dorra Elhaj, et al.
Publicado: (2022)

Primitive pelvic bone hydatidosis: What an amazing extension
por: Boussaid, Soumaya, et al.
Publicado: (2021)

Targeting nanomedicines in the treatment of rheumatoid arthritis: focus on certolizumab pegol
por: Barnes, Theresa, et al.
Publicado: (2007)

Spinal Tuberculosis: Features and Early Predictive Factors of Poor Outcomes
por: Boussaid, Soumaya, et al.
Publicado: (2023)

Two Dosing Regimens of Certolizumab Pegol in Patients With Active Rheumatoid Arthritis
por: Furst, D E, et al.
Publicado: (2015)

Factors associated with successful discontinuation of certolizumab pegol in early rheumatoid arthritis
por: Tanaka, Yoshiya, et al.
Publicado: (2020)

Prefilled certolizumab pegol (Cimzia(®)) syringes for self-use in the treatment of rheumatoid arthritis
por: Rosa, J, et al.
Publicado: (2010)

Certolizumab pegol in a heterogeneous population of patients with moderate-to-severe rheumatoid arthritis
por: Soriano, Enrique R, et al.
Publicado: (2018)

Certolizumab Pegol-Induced Folliculitis-Like Lichenoid Sarcoidosis in a Patient with Rheumatoid Arthritis
por: Sakai, Hiroyuki, et al.
Publicado: (2017)

SFRP5 Enhances Wnt5a Induced-Inflammation in Rheumatoid Arthritis Fibroblast-Like Synoviocytes
por: Mahmoud, Dorra Elhaj, et al.
Publicado: (2021)

Certolizumab pegol treatment for leg ulcers due to rheumatoid vasculitis
por: Meling, Maureen Tania, et al.
Publicado: (2021)

Focal Segmental Glomerulosclerosis and Hyalinosis in a Patient with Spondyloarthritis: A Rare Renal Involvement Case Report
por: Boussaid, Soumaya, et al.
Publicado: (2023)

Renal sarcoidosis associated with certolizumab pegol treatment for psoriatic arthritis
por: Hum, Ryan M, et al.
Publicado: (2022)

Certolizumab pegol in the treatment of rheumatoid arthritis: a comprehensive review of its clinical efficacy and safety
por: Mease, Philip J.
Publicado: (2011)

Update on the safety profile of certolizumab pegol in rheumatoid arthritis: an integrated analysis from clinical trials
por: Bykerk, V P, et al.
Publicado: (2015)

Scintigraphic detection of TNF-driven inflammation by radiolabelled certolizumab pegol in patients with rheumatoid arthritis and spondyloarthritis
por: Carron, Philippe, et al.
Publicado: (2016)

Real-World Methotrexate Dose on Clinical Effectiveness and Structural Damage of Certolizumab Pegol With Rheumatoid Arthritis
por: Nozaki, Yuji, et al.
Publicado: (2021)

Tachon Syndrome: Rare Side Effect of Articular Injections of Corticosteroids. A Report of Two Cases
por: Rekik, Sonia, et al.
Publicado: (2017)

5. Certolizumab Pegol for RA in pregnancy
por: Thorne, Iona, et al.
Publicado: (2017)

Impact of certolizumab pegol on patient-reported outcomes in rheumatoid arthritis and correlation with clinical measures of disease activity
por: Pope, Janet, et al.
Publicado: (2015)

The efficacy of certolizumab pegol in rheumatoid arthritis assessed by gray scale and power Doppler ultrasonography: case reports
por: Mendonça, José Alexandre, et al.
Publicado: (2019)

Long-Term Maintenance of Certolizumab Pegol Safety and Efficacy, in Combination with Methotrexate and as Monotherapy, in Rheumatoid Arthritis Patients
por: Fleischmann, Roy, et al.
Publicado: (2017)

Exposure–Response Relationship of Certolizumab Pegol and Achievement of Low Disease Activity and Remission in Patients With Rheumatoid Arthritis
por: Paul, Stéphane, et al.
Publicado: (2020)

Systemic Sarcoidosis Associated with Certolizumab Pegol Treatment for Rheumatoid Arthritis: A Case Report and Review of the Literature
por: Koda, Keigo, et al.
Publicado: (2020)

Eosinophilic Annular Erythema due to Certolizumab Pegol Therapy for Rheumatoid Arthritis Post-COVID-19 Vaccine
por: Bassi, Andrea, et al.
Publicado: (2023)

Drug Induced Thrombotic Microangiopathy with Certolizumab Pegol
por: Baysal, Mehmet, et al.
Publicado: (2018)

Treatment of Rheumatoid Arthritis with Certolizumab Pegol: Results from PROACTIVE, a Non-Interventional Study in the UK and Ireland
por: Kumar, Namita, et al.
Publicado: (2018)

Certolizumab Pegol in the Treatment of Psoriasis and Psoriatic Arthritis: Preliminary Real-Life Data
por: Dattola, Annunziata, et al.
Publicado: (2017)

A cross sectional study of bone and cartilage biomarkers: correlation with structural damage in rheumatoid arthritis
por: Ben Achour, Wael, et al.
Publicado: (2018)

Certolizumab pegol in rheumatoid arthritis patients with low to moderate activity: the CERTAIN double-blind, randomised, placebo-controlled trial
por: Smolen, J S, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_vi8m9nl44kseu2asl4qg3juqhs